ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 249,88
0,76%
Dow Jones
39 387,76
0,85%
DAX
18 827,98
0,79%
Brent Oil
83,90
-0,06%
Bitcoin
62 985,52
-0,10%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Corbus Pharmaceuticals Holdings Inc (CRBP)

  7. Corbus Pharmaceuticals Holdings Inc (CRBP) Actualités

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CRBP
DateHeureSourceTitreSymboleSociété
09/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/05/202422h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202423h09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/01/202415h16Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202413h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
13/06/202322h59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/06/202322h54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/06/202312h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/05/202322h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
19/05/202315h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/05/202323h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202322h32Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202322h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
10/03/202322h32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202322h30Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202316h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
15/02/202312h07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/11/202223h51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/11/202212h25TipRanksCorbus Pharmaceuticals (CRBP) Gets a Buy from H.C. WainwrightNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/10/202214h05PR Newswire (US)Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/10/202223h09Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
26/09/202214h05PR Newswire (US)Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/09/202214h00PR Newswire (US)Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/09/202213h00PR Newswire (US)Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRBP

Dernières Valeurs Consultées

EU
GLE
Societe Generale
EU
PX1
CAC 40
FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
EU
BN
Danone
EU
ACA
Credit Agricole
EU
PX4
SBF 120
NYSE
MCD
McDonalds
EU
EN
Bouygues
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés